🔎 Trials Near Me

መነሻ › Metastatic Cancer › ካሊፎርኒያ › Sacramento

በSacramento፣ CA ለMetastatic Cancer የሚደረጉ ክሊኒካዊ ጥናቶች

ለMetastatic Cancer የሚደረጉ 16 ጥናቶች በSacramento እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Mercy Cancer Center - Sacramento, Sacramento
  • Woodland Memorial Hospital, Woodland · 16 ማይል ርቀት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ5 ኦክቶ 2026 · NCT05564377

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05372614

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of California, Davis Comprehensive Cancer Center, Sacramento
  • University of California, Davis Medical Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07222800

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Research Site, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06103864

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05118789

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of California Davis (UC Davis) Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07218380

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UC Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of California Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT06389123

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California (UC) Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT05614739

TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁላይ 2026 · NCT07189195

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sutter Institute for Medical Research, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ጁን 2026 · NCT06216301

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California Davis, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ጁን 2026 · NCT06917079

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of California, Davis Comprehensive Cancer Center, Sacramento
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ሜይ 2026 · NCT05384626

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California, Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT06521554

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • University of California Davis Comprehensive Cancer Center, Sacramento
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

በሌሎች ከተሞች ለMetastatic Cancer የሚደረጉ ጥናቶች

በSacramento ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።